Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

Avita Medical Ltd. (AVMXF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Avita Medical develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The company’s lead product, ReCell® Spray-On Skin™, is CE-marked for Europe, TGA-registered in Australia, and SFDA-cleared in China. … Continue reading →

Posted in EBD Group Conference | Leave a comment

MiMedx Group, Inc. (MDXG) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

MiMedx Group is an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants that are processed from human amniotic membrane. The company’s mission is to provide physicians with products and tissues to help the body heal itself. … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Agenus, Inc. (AGEN) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including a number of product candidates … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Amorfix Life Sciences Ltd. (ARFXF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s Disease. The company offers two types of products: therapeutics, designed to target and neutralize only the misfolded conformation … Continue reading →

Posted in EBD Group Conference | Leave a comment

RXi Pharmaceuticals Corp. (RXII) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in 2012. The candidate is initially … Continue reading →

Posted in EBD Group Conference | Leave a comment

Immunomedics, Inc. (IMMU) Receives Notice for Patent Application on Hexavalent Complexes

Posted on January 8, 2013 by MissionIR

Immunomedics is a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune diseases, and other serious diseases. The company also has a majority ownership in IBC Pharmaceuticals, which is developing a … Continue reading →

Posted in Small Cap News | Leave a comment

ADVENTRX Pharmaceuticals, Inc. (ANX) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications arising from sickle cell disease … Continue reading →

Posted in OneMedForum Conference | Leave a comment

NanoViricides, Inc. (NNVC) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles. NanoViricides is developing drugs against … Continue reading →

Posted in OneMedForum Conference | Leave a comment

ERBA Diagnostics Inc. (ERB) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers & Fully Automated), Haematology analyzers, Urine … Continue reading →

Posted in EBD Group Conference | Leave a comment

Viropro (VPRO) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins … Continue reading →

Posted in EBD Group Conference | Leave a comment